Bisacodyl Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg
Reference Brands: Dulcolax:(US & EU)
Category:
Gastrointestinal Drugs
Bisacodyl 5 mg tablets are stimulant laxatives that increase intestinal motility by stimulating nerve plexuses in the colon. They promote bowel movements, relieve constipation, and support bowel cleansing before diagnostic procedures. Benefits include quick relief, effective stool softening, and enhanced bowel evacuation, supporting gastrointestinal health.
Bisacodyl tablets is available in Tablets
and strengths such as 5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bisacodyl tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bisacodyl tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bisacodyl 5 mg tablets, marketed as Dulcolax, are approved in the US by the FDA and in the EU via EMA for short-term constipation relief. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and worldwide availability of bisacodyl tablets, helping patients manage constipation effectively across regions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing